在炎症性肠道疾病中使用数字健康工具
Iago Rodríguez-Lago1, Beatriz Gros2, Kristy Sánchez3
1Servicio de Aparato Digestivo, Hospital Universitario de Galdakao; Instituto de Investigación Sanitaria Biobizkaia, Galdakao, Vizcaya, España.
Gastroenterologia y hepatologia
|May 9, 2024
概括
医疗保健专业人员经常使用数字健康工具 (DHT) 来治疗炎症性肠病 (IBD). 然而,优化它们的有效和安全使用需要进一步采取行动,以解决时间限制和信息过载等障碍.
科学领域:
- 胃肠病学 胃肠病学
- 数字健康数字健康
- 医疗信息学 医疗信息学
背景情况:
- 炎症性肠病 (IBD) 管理越来越多地涉及数字健康工具 (DHT).
- 在医疗保健专业人员中了解DHT的特征和使用模式对于有效的患者护理至关重要.
研究的目的:
- 在炎症性肠病 (IBD) 的背景下分析数字健康工具 (DHT) 的特性和使用情况.
- 为了确定障碍和促进者,通过和有效使用DHT的医疗保健专业人员在IBD护理.
主要方法:
- 一项定性研究,结合了叙事文献评论,向医疗保健专业人员分发的问卷和胃肠病学家的专家意见.
- 通过Medline进行了搜索,直到2022年9月,以确定有关在IBD中使用DHT的相关文章.
- 一个结构化的问卷收集了参与IBD患者护理的专业人士的见解.
主要成果:
- 对于IBD,存在多种DHT,它们的特征和含量各不相同.
- 96%的受访医疗保健专业人员报告使用DHT,主要用于信息收集 (80%),临床实践 (70%) 和教育 (62%).
- 主要障碍包括缺乏时间 (55%),对福利的不确定性 (50%) 和信息过载 (40%).
结论:
- 医疗保健专业人员积极使用DHT来管理炎症性肠病 (IBD).
- 需要进行战略性干预,以提高DHT在IBD护理中的使用效率和安全性.
- 解决已识别的障碍对于优化数字健康在IBD管理中的作用至关重要.
相关概念视频
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
01:29Inflammatory Bowel Disease IV: Pharmacological Management
126
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
126
01:30Inflammatory Bowel Disease II: Crohn's Disease
219
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
219
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
166
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
166
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
131
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
131
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
158
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
158